DSM Anti-Infectives enters into partnership with Indian company Arch Pharmalabs Ltd.
10-Dec-2007
"This will accelerate the development of new products for DSM Anti-Infectives" commented Gerard de Reuver, Business Group Director DSM Anti-Infectives.
As announced in June 2007, DSM Anti-Infectives is currently rationalizing its portfolio and actively looking for partnerships. A part of the current portfolio (such as clavulanic acid) will be divested and new products will be developed.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.